


Healthcare News Roundup: FDA
HSMN NewsFeed - 11 Dec 2019
Correvio Announces Intention to Explore Strategic Alternatives to Maximize Stakeholder Value
Correvio Announces Intention to Explore Strategic Alternatives to Maximize Stakeholder Value
HSMN NewsFeed - 10 Dec 2019
Neuspera Medical Receives Investigational Device Exemption for Its Ultra-Miniaturized Implantable Device
Neuspera Medical Receives Investigational Device Exemption for Its Ultra-Miniaturized Implantable Device
HSMN NewsFeed - 9 Dec 2019
BIOLASE Announces Clearance of the Epic Hygiene Laser for Dental Hygienists
BIOLASE Announces Clearance of the Epic Hygiene Laser for Dental Hygienists
HSMN NewsFeed - 2 Dec 2019
Cumberland Pharmaceuticals Receives FDA Approval for RediTrex(TM) Product Line
Cumberland Pharmaceuticals Receives FDA Approval for RediTrex(TM) Product Line
HSMN NewsFeed - 26 Nov 2019
Evofem Biosciences Resubmits New Drug Application to U.S. FDA for Amphora(R) for the Prevention of Pregnancy
Evofem Biosciences Resubmits New Drug Application to U.S. FDA for Amphora(R) for the Prevention of Pregnancy
HSMN NewsFeed - 14 Nov 2019
Ultromics Receives FDA Clearance for its AI-powered Decision Support System, EchoGo Core
Ultromics Receives FDA Clearance for its AI-powered Decision Support System, EchoGo Core
HSMN NewsFeed - 11 Nov 2019
AI Medical Service Inc. announces FDA Breakthrough Device Designation for endoscopic AI system
AI Medical Service Inc. announces FDA Breakthrough Device Designation for endoscopic AI system
HSMN NewsFeed - 5 Nov 2019
Nevro Announces U.S. Launch of Senza(R) Omnia(TM) Spinal Cord Stimulation System to Treat Chronic Pain
Nevro Announces U.S. Launch of Senza(R) Omnia(TM) Spinal Cord Stimulation System to Treat Chronic Pain
HSMN NewsFeed - 31 Oct 2019
Stryker receives FDA clearance for SAHARA(R) Lateral 3D Expandable Interbody System
Stryker receives FDA clearance for SAHARA(R) Lateral 3D Expandable Interbody System
HSMN NewsFeed - 30 Oct 2019
Biogen and Alkermes Announce FDA Approval of VUMERITY(TM) (diroximel fumarate) for Multiple Sclerosis
Biogen and Alkermes Announce FDA Approval of VUMERITY(TM) (diroximel fumarate) for Multiple Sclerosis
